Retraction Note: Cancer Cell Int (2019) 19:156 https://doi.org/10.1186/s12935-019-0879-x
The Editors-in-Chief have retracted this article at the corresponding author's request. After publication, the authors found that the data could not be replicated. This was caused by mislabelling of patient blood samples and the use of contaminated cell lines (SGC-7901, BGC-823 and MGC-803) in this study.
The authors therefore no longer have confidence in the presented results.
All authors agree to this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Guo, J., Li, Y., Duan, H. et al. Retraction Note: LncRNA TUBA4B functions as a competitive endogenous RNA to inhibit gastric cancer progression by elevating PTEN via sponging miR-214 and miR-216a/b. Cancer Cell Int 22, 408 (2022). https://doi.org/10.1186/s12935-022-02823-4
Accepted:
Published:
DOI: https://doi.org/10.1186/s12935-022-02823-4